TB under the microscope

  • April 18, 2012
TB under the microscope

A new organisation will bring together experts on global health to tackle major diseases.

The chief medical officer of pharmaceutical giant GlaxoSmithKline will give the keynote address at a conference dedicated to finding new ways to tackle diseases which disproportionately affect developing countries.

The Cambridge Global Health Commercialization & Funding Roundtable has been organised by three Gates Cambridge scholars and two other students and takes place this Thursday and Friday.

Ellen Strahlmanfrom GlaxoSmithKline will give the keynote address on Thursday and Friday is reserved for a series of panel discussions on the theme of tuberculosis, including social entrepreneurship in TB delivery, global health funding and TB vaccines.

Among those taking part are Christopher Dye, Director of Health Information in the Office of HIV/AIDS, Tuberculosis, Malaria and Neglected Tropical Diseases at the World Health Organization; Patrick Gihana-Mulenga, the Rwanda High Commission Commercial Attaché; Bina Rawal, Head of Clinical Development in the Technology Transfer Division of the Wellcome Trust; Davino Sena, Head of Science and Technology at the Embassy of Brazil in London; Shelly Batra, President of OperationASHA; Suresh Jadhav, Executive Director of the Serum Institute of India Ltd; and David Brown, Adviser of One World Health. Global experts in tackling health problems, including academics, funding and investment companies, biotechnology companies and vaccine manufacturers are also taking part.

Gates Cambridge scholar Julia Fan Li [2008] is the chairperson of the GHCF Roundtable. The organising team is Priya Khetarpal, Tomas Niklitschek and Gates Cambridge scholars Nicole Person-Rennell [2011] and Diana Pirjol [2011].

The Roundtable was set up to examine entrepreneurial activity in global health and to explore opportunities and business models to reconcile healthcare innovation and access. It brings together entrepreneurs, scientists, civil society, investors, funders, academics and ecosystem participants to explore business models in the discovery, development and delivery of global health innovations.

Its aims include sharing best practices of existing business models, stimulating new thinking upon the catalytic resource providers of both grant and investment-funding and encouraging awareness and public engagement on the issue of global health.

“We are really excited to be examining biomedical innovation from a holistic perspective.” says Julia Fan Li, “and pleased to welcome passionate global health experts from all over the world to Cambridge.”

For more information, click here.

Photo credit: Creative Commons, Ray Butler, CDC and Microbe World.

Latest News

Cambridge event for new book by leading thinkers

Artificial intelligence gets a lot of bad press, but if harnessed correctly has the ability to create jobs and drive growth through enhancing productivity and helping countries level up, according to a new book by some of the world’s leading thinkers. The book, Permacrisis: A Plan to Fix a Fractured World, explores pressing global issues […]

Rainforest carbon credit schemes less effective than thought, claims report

The effectiveness of widely used rainforest carbon credit schemes has been called into question by a new study. The study, Reducing Emissions from Deforestation and Forest Degradation (REDD+) Carbon Crediting,  by the Berkeley Carbon Trading Project is co-authored by Gates Cambridge Scholar Libby Blanchard [2012] and has been making headlines around the world. It brings […]

Gates Cambridge Trust seeks Global Engagement Officer

About us  Gates Cambridge Scholarships are prestigious, highly competitive, full-cost scholarships awarded to outstanding applicants from countries outside the UK to pursue a full-time postgraduate degree in any subject available at the University of Cambridge. Gates Cambridge Scholars become part of a lifelong global community defined by its core value of commitment to improving the […]

How combining clinical data could improve traumatic brain injury outcomes

Researchers, led by a Gates Cambridge Scholar, have integrated all medical data collected from traumatic brain injury (TBI) patients to calculate, for the first time, the personalised contribution of each clinical event to long-term recovery. This international effort marks a step towards patient-centred treatment in the intensive care unit (ICU). Shubhayu Bhattacharyay [2020] is the lead […]